CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-07-23 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion | +5,681 | $31.64 | $180K | 7,000 |
| 2015-07-23 | Goddard Glenn Senior Vice President, Finance | Sale | −7,000 | $120.45 | $843K | 0 |
| 2015-07-23 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −1,319 | 94,779 | ||
| 2015-07-23 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −5,681 | 89,098 | ||
| 2015-07-20 | Biller Scott Chief Scientific Officer | Exercise or conversion | +5,500 | $31.64 | $174K | 39,570 |
| 2015-07-20 | Biller Scott Chief Scientific Officer | Sale | −5,500 | $113.87 | $626K | 34,070 |
| 2015-07-20 | Biller Scott Chief Scientific Officer | Exercise or conversion · Stock option (right to buy) | −5,500 | 301,880 | ||
| 2015-07-17 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion | +909 | $0.69 | $625 | 909 |
| 2015-07-17 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion | +7,273 | $2.34 | $17K | 8,182 |
| 2015-07-17 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion | +3,725 | $9.05 | $34K | 11,907 |
| 2015-07-17 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion | +1,093 | $23.10 | $25K | 13,000 |
| 2015-07-17 | Goddard Glenn Senior Vice President, Finance | Sale | −13,000 | $113.71 | $1.5M | 0 |
| 2015-07-17 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −909 | 108,189 | ||
| 2015-07-17 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −7,273 | 100,916 | ||
| 2015-07-17 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −3,725 | 97,191 | ||
| 2015-07-17 | Goddard Glenn Senior Vice President, Finance | Exercise or conversion · Stock option (right to buy) | −1,093 | 96,098 | ||
| 2015-07-16 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $114.17 | $277K | 157,558 |
| 2015-07-16 | Cantley Lewis Clayton Jr. Director | Sale | −2,426 | $114.20 | $277K | 157,558 |
| 2015-07-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +8,264 | $0.30 | $2K | 130,099 |
| 2015-07-16 | Higgons John Duncan Chief Operating Officer | Exercise or conversion | +11,736 | $0.30 | $4K | 141,835 |
Page 88 of 93 · 1,853 trades